Advertisement

Abstract

Keloids and hypertrophic scars are benign, localized proliferations of connective tissue of the skin and are the result of abnormal wound healing. Excessive scars may develop following any injury of a deep dermis, including burns, surgery, abrasion, piercings, vaccinations, and lacerations.

Keywords

Keloid Hypertrophic scar Intralesional Cryotherapy Silicone 

Further Reading

  1. Akaishi S, Koike S, Dohi T, Kobe K, Hyakusoku H, Ogawa R. Nd:YAG laser treatment of keloids and hypertrophic scars. Eplasty. 2012;12:e1.PubMedPubMedCentralGoogle Scholar
  2. Alster TS, Tanzi EL. Hypertrophic scars and keloids: etiology and management. Am J Dermatol. 2003;4:235–43.CrossRefGoogle Scholar
  3. Brown P, Miller ME, Bandino J, Hivnor C. Laser treatment of scars and keloids. Cosmet Dermatol. 2012;25:318–25.Google Scholar
  4. Butler PD, Longaker MT, Yang GP. Current progress in keloid research and treatment. J Am Coll Surg. 2008;206:731–41.CrossRefGoogle Scholar
  5. Camacho ID, Nouri K. Hypertrophic scars and keloids: what can lasers do? Cosmet Dermatol. 2007;20:156–60.Google Scholar
  6. Caviggioli F, Maione L, Vinci V, Klinger M. The most current algorithms for the treatment and prevention of hypertrophic scars and keloids. Plast Reconstr Surg. 2010;126:1130–1.CrossRefGoogle Scholar
  7. Chernoff WG, Cramer H, Su-Huang S. The efficacy of topical silicone gel elastomers in the treatment of hypertrophic scars, keloid scars, and post-laser exfoliation erythema. Aesthetic Plast Surg. 2007;31:495–500.CrossRefGoogle Scholar
  8. Eishi K, Bae SJ, Ogawa F, Hamasaki Y, Shimizu K, Katayama I. Silicone gel sheets relieve pain and pruritus with clinical improvement of keloid: possible target of mast cells. J Dermatolog Treat. 2003;14:248–52.CrossRefGoogle Scholar
  9. Gauglitz GG. Management of keloids and hypertrophic scars: current and emerging options. Clin Cosmet Investig Dermatol. 2013;6:103–14.CrossRefGoogle Scholar
  10. Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG. Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med. 2011;17:113–25.CrossRefGoogle Scholar
  11. Gupta S, Sharma VK. Standard guidelines of care: keloids and hypertrophic scars. Indian J Dermatol Venereol Leprol. 2011;77:94–100.CrossRefGoogle Scholar
  12. Hanasono MM, Lum J, Carroll LA, Mikulec AA, Koch RJ. The effect of silicone gel on basic fibroblast growth factor levels in fibroblast cell culture. Arch Facial Plast Surg. 2004;6:88–93.CrossRefGoogle Scholar
  13. Juckett G, Hartman-Adams H. Management of keloids and hypertrophic scars. Am Fam Physician. 2009;80:253–60.PubMedGoogle Scholar
  14. Köse O, Waseem A. Keloids and hypertrophic scars: are they two different sides of the same coin? Dermatol Surg. 2008;34:336–46.PubMedGoogle Scholar
  15. Kranendonk S, Obagi S. An algorithmic approach to hypertrophic scars and keloids: maximizing nonsurgical options. Cosmet Dermatol. 2011;24:28–39.Google Scholar
  16. Maderal AD, Tang JC, Vivas AC, Viera MH. Hypertrophic scars and keloids, Part 2: newer and investigational therapies. Cosmet Dermatol. 2012;25:373–9.Google Scholar
  17. Mustoe TA. Evolution of silicone therapy and mechanism of action in scar management. Aesthetic Plast Surg. 2008;32:82–92.CrossRefGoogle Scholar
  18. Mutalik S. Treatment of keloids and hypertrophic scars. Indian J Dermatol Venereol Leprol. 2005;71:3–8.CrossRefGoogle Scholar
  19. Nast A, Eming S, Fluhr J, Fritz K, Gauglitz G, Hohenleutner S, et al. German S2k guidelines for the therapy of pathological scars (hypertrophic scars and keloids). J Dtsch Dermatol Ges. 2012;10:747–62.PubMedGoogle Scholar
  20. Nouri K, Vidulich K, Rivas MP. Lasers for scars: a review. J Cosmet Dermatol. 2006;5:14–22.CrossRefGoogle Scholar
  21. Ogawa R. The most current algorithms for the treatment and prevention of hypertrophic scars and keloids. Plast Reconstr Surg. 2010;125:557–68.CrossRefGoogle Scholar
  22. Profyris C, Tziotzios C, Do VI. Cutaneous scarring: pathophysiology, molecular mechanisms, and scar reduction therapeutics Part I. The molecular basis of scar formation. J Am Acad Dermatol. 2012;66:1–10.CrossRefGoogle Scholar
  23. Reish RG, Eriksson E. Scar treatments: preclinical and clinical studies. J Am Coll Surg. 2008;206:719–30.CrossRefGoogle Scholar
  24. Robles DT, Berg D. Abnormal wound healing: keloids. Clin Dermatol. 2007;25:26–32.CrossRefGoogle Scholar
  25. Shaffer JJ, Taylor SC, Cook-Bolden F. Keloidal scars: a review with a critical look at therapeutic options. J Am Acad Dermatol. 2002;46 Suppl 2:S63–97.CrossRefGoogle Scholar
  26. Tollefson TT, Kamangar F, Aminpour S, Lee A, Durbin-Johnson B, Tinling S. Comparison of effectiveness of silicone gel sheeting with microporous paper tape in the prevention of hypertrophic scarring in a rabbit model. Arch Facial Plast Surg. 2012;14:45–51.CrossRefGoogle Scholar
  27. Tziotzios C, Profyris C, Sterling J. Cutaneous scarring: pathophysiology, molecular mechanisms, and scar reduction therapeutics Part II. Strategies to reduce scar formation after dermatologic procedures. J Am Acad Dermatol. 2012;66:13–24.CrossRefGoogle Scholar
  28. Viera MH, Amini S, Valins W, Berman B. Innovative therapies in the treatment of keloids and hypertrophic scars. J Clin Aesthet Dermatol. 2010;3:20–6.PubMedPubMedCentralGoogle Scholar
  29. Vivas AC, Tang JC, Maderal AD, Viera MH. Hypertrophic scars and keloids, Part 1: conventional treatments. Cosmet Dermatol. 2012;25:309–16.Google Scholar
  30. Wolfram D, Tzankov A, Pülzl P, Piza-Katzer H. Hypertrophic scars and keloids—a review of their pathophysiology, risk factors, and therapeutic management. Dermatol Surg. 2009;35:171–81.CrossRefGoogle Scholar
  31. Yamamoto T. Bleomycin and the skin. Br J Dermatol. 2006;155:869–75.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  1. 1.Clinic of Dermatovenerology, Clinical Center NišUniversity of NišNišSerbia

Personalised recommendations